Clinical Trial

HPV Self-sampling in the General Population

Study acronym: MIRABELLE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 23, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
A randomized controlled trial comparing three strategies for cervical cancer screening: direct mailing of HPV self-sampling kit ("Outreach" arm), choice between self-sampling or healthcare provider sampling ("Choice" arm), and standard care (control arm) in two French departments.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-19.
Status change: Not Yet Recruiting → Recruiting 2025-07-22
Trial Details
NCT Number NCT06749847
Lead Sponsor International Agency for Research on Cancer
Collaborators: National Cancer Institute, France, Central Hospital, Nancy, France, CHU de Reims
Conditions Cervical Cancer
Enrollment 6,000 participants
Start Date 2025-06-26
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-23